Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial

Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial

Bibliographic Details
Main Authors: Jacques P. Brown, Arkadi Chines, Roland Chapurlat, Joseph Foldes, Xavier Nogues, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano Zerbini, Wenjing Yang, Chris Recknor, Cesar Libanati
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Bone Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187220300863

Internet

http://www.sciencedirect.com/science/article/pii/S2352187220300863

Similar Items